Achillion pharmaceuticals inc (ACHN)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-19,583

-19,426

-18,959

-16,601

-15,884

-17,199

-20,588

-23,203

-19,338

-22,543

-20,152

-4,429

-20,730

-18,493

-18,054

16,952

26,259

-28,978

-19,263

-21,596

-15,667

-15,657

-16,088

-13,350

-13,919

-19,940

-11,738

-11,204

-15,255

-11,527

-9,141

-12,385

-10,438

-11,250

-10,133

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

272

296

300

300

287

282

289

284

277

270

295

265

258

240

192

189

184

161

160

136

121

121

111

-

-

-

98

89

110

109

100

91

89

73

74

Non-cash stock-based compensation

1,707

1,588

1,566

1,884

1,611

3,550

2,335

2,209

2,405

2,783

3,176

2,706

2,687

2,637

2,976

2,588

2,173

2,394

2,917

2,517

1,559

1,641

1,556

1,600

1,233

1,664

1,423

1,263

934

815

920

1,005

658

678

648

Premium on purchases of marketable securities

-

-

-

0

0

274

-215

-

-

-

-

401

-436

355

245

428

699

320

1,039

28

195

183

541

-

-

-

-

-

-

-

-

-

-

-

-

Premium on purchases of marketable securities

-

-

-

-

-

-

-

-

212

625

492

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of (discount) premium on marketable securities

473

703

699

475

326

31

-191

-350

-353

-196

-180

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

9

Premium on purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

166

176

2,901

133

757

72

-207

-

-

-

-

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

128

413

383

569

533

515

385

349

482

528

600

683

721

707

249

130

111

105

98

127

154

87

110

Changes in operating assets and liabilities:
Accounts and other receivables

-179

-801

866

268

-236

-32

290

-231

62

-230

-14,797

14,871

-501

-31

411

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts and other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

711

-

-152

-439

153

444

-573

20

312

-186

37

409

-86

10

-260

260

-153

Prepaid expenses and other assets

50

-92

-422

-235

-563

-434

1,474

-1,191

511

593

400

706

-286

762

-461

580

-144

771

-370

-139

93

463

-992

323

-490

-1,156

1,427

-110

355

-445

957

-610

126

-962

707

Accounts payable

-1,478

2,564

-271

690

219

-1,049

-2,800

-2,890

5,227

-1,165

-2,749

1,598

-254

-1,059

2,408

-781

-6,488

3,462

1,522

3,782

632

-1,637

-950

-254

-1,716

1,368

917

-1,590

998

-28

101

727

-100

273

1,223

Operating lease right-of-use asset

-218

-246

-326

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

265

261

257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,662

-1,424

831

1,403

1,115

-1,846

-565

1,901

521

-2,039

1,827

553

161

-74

347

1,275

399

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-2,489

-

-

-

-

Accrued expenses and other liabilities

-

680

711

-

-

1,043

-1,976

-

-

4,590

-455

-

-

397

-3,894

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-5,800

-

-15,371

-16,943

-16,184

-15,618

55,430

-16,914

-17,321

-16,180

-12,178

-13,808

-13,358

-13,975

-13,250

-13,241

-13,170

-

-

-

-

-

-

-

-

Net cash used in operating activities

-16,470

-14,076

-17,727

-11,702

-13,000

-13,212

-24,098

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,154

-9,865

-11,328

-10,014

-9,492

-8,406

-8,224

Cash flows from investing activities
Purchases of fixed assets

86

21

70

47

116

174

178

79

213

120

214

743

510

861

394

93

290

247

74

630

71

28

218

163

7

95

143

28

52

101

475

139

96

492

5

Purchases of marketable securities

-

45,890

65,515

-

-

62,154

62,229

79,806

57,079

86,984

121,621

95,083

73,228

158,341

172,463

220,799

227,767

34,851

209,108

10,535

13,776

13,509

41,518

19,605

3,565

25,200

119,747

8,708

38,206

6,345

26,500

7,301

53,875

8,310

10,220

Maturities of marketable securities

99,050

45,000

83,105

75,142

62,960

73,104

78,685

91,507

90,626

96,239

93,719

149,392

95,749

151,036

166,115

167,446

102,078

64,446

60,605

18,003

24,653

25,048

55,921

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,265

16,165

20,700

-

10,500

5,000

49,950

10,080

4,950

8,500

22,244

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-28,116

-

22,011

-8,166

-6,742

-53,446

-125,979

29,348

-148,577

6,838

10,806

11,511

14,185

21,593

21,693

-9,130

-99,190

-

-

-

-

-

-

-

-

Net cash provided by investing activities

21,642

-909

17,520

25,064

14,198

10,776

16,278

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-27,758

-1,446

22,975

2,640

-49,021

-302

12,019

Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

158,877

-31

138,291

-

-

-

-

-

0

0

133,211

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

170

9

570

1,304

0

37

0

2

-

-

-

-

257

459

2,487

527

100

2,517

1,445

5

218

39

191

107

252

889

79

1,158

59

31

439

41

Payment of deferred financing costs

-

-

-

-

-

-

-

0

0

0

175

-

-

-

-

-

-

-

-

-

0

5

77

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

229

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of debt

0

0

131

38

37

37

58

69

96

93

93

81

55

56

54

52

54

52

90

76

54

92

91

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

609

-

-

-

-

Repayments of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

86

-

82

81

35

34

34

0

478

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-266

-

-55

141

-54

358

159,282

2,541

138,957

43,396

7,714

1,444

-163

209

-50

210

133,232

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

0

10

Net cash provided by financing activities

3,519

370

-131

176

-28

635

1,246

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,489

86

1,732

96

-24

61,912

-447

Net decrease in cash and cash equivalents

8,691

-14,615

-338

13,538

1,170

-1,801

-6,574

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-34,182

-

6,585

-24,968

-22,980

-68,706

88,733

14,975

-26,941

34,054

6,342

-853

664

7,827

8,393

-22,161

20,872

-2,315

2,577

-11,225

13,379

-7,278

-58,537

53,204

3,348

Supplemental disclosure of cash flow information
Cash paid for interest

1

8

9

11

5

8

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash activities
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

17

-

8

11

14

11

11

7

21

10

5

8

12

10

9

13

14

14

13

24

9

13

7

2

11

Cashless exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of fixed assets in accounts payable and accrued expenses

-

-

-

38

-34

-24

69

8

-58

5

81

-144

-126

30

439

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset and liability (non-cash adoption balances)

0

0

1,889

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,187

9,868

2,051

-

-

-

-